Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI. - sprookjes - yvandenbroek - TriplyDB

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

http://www.wikidata.org/entity/Q35547240

about

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

http://www.wikidata.org/entity/Q35547240

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

@ast

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

@en

type

label

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

@ast

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

@en

prefLabel

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

@ast

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

@en

P1433

Q35547240-C53C8EFC-59CD-4F7F-9E5C-264CACB2C00B

P1476

Q35547240-74DB5A2F-2716-4DF9-9C77-B2D05B18D1CB

P2093

Q35547240-202AF649-E4A2-4FDE-A16F-326B22494062

Q35547240-403F4429-452C-4605-B136-5538433C02E6

Q35547240-5DE0A2AB-08A1-43E5-82CF-749076933E37

Q35547240-788F51B7-0DA4-4999-9ED0-CA581167F43A

Q35547240-78AC2EA4-05FC-4F44-A08F-B3437EA74E50

Q35547240-F59E5265-769D-4751-AD9E-8350622C8C63

P2860

Q35547240-0724067C-F999-4585-B137-CBA5CF31C28C

Q35547240-08EDCAE3-870F-4929-B48A-FB07BC973AD0

Q35547240-19FC4ECC-602B-4A6D-A549-1BA517927EAA

Q35547240-1E0845E9-6688-4978-A16A-99E537EDDF67

Q35547240-2B27EC43-1F5B-4B88-B475-FC44F6394AAC

Q35547240-356CB6F2-7370-4E48-A199-AD0A7A94AAB9

Q35547240-397205B0-1ADD-46A9-BF06-A407380B2864

Q35547240-3C72AD2F-8A79-4F04-84B2-A2EE1F76BF4A

Q35547240-6C7A42FA-F9E8-46A6-BECE-404F5E4BA6DA

Q35547240-855C7688-A715-4B0B-8AFF-FDC74A79AA01

P304

Q35547240-33A67693-444D-41E1-9B1E-01438F50D3F1

P31

Q35547240-B0DC3E80-69E8-4F3E-AEC3-2B621A526C06

P356

Q35547240-71B22A6A-FEF7-4B33-A52E-2CAFA7A44935

P407

Q35547240-994AEF3E-5A2A-4ACF-8D9F-5AC3B6CA085C

P433

Q35547240-2DE3C00B-1F06-4698-968D-78E910BD5B16

P478

Q35547240-E682E0B4-7B52-493B-A5FD-D2F02DC04101

P577

Q35547240-04EB8D13-F220-451F-9D55-F4E5EE94FED7

P5875

Q35547240-1B552D08-0A0D-40C2-9270-E9ECD41F3DE5

P698

Q35547240-44EE3742-0570-4ACD-8F0F-411EB6FAE3C1

P356

P1433

Annals of Pharmacotherapy

P1476

Outcomes with changes in prescribing of glycoprotein IIb/IIIa inhibitors in PCI.

@en

P2093

Jonathan E Lakamp

http://www.w3.org/2001/XMLSchema#string

Joy R Abu-Shanab

http://www.w3.org/2001/XMLSchema#string

Maged Y Haikal

http://www.w3.org/2001/XMLSchema#string

Paul P Dobesh

http://www.w3.org/2001/XMLSchema#string

Sara L Lanfear

http://www.w3.org/2001/XMLSchema#string

Siddhesh Gowda

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention

Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization.

Thrombolysis in Myocardial Infarction (TIMI) Trial--phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty.

Results of primary percutaneous transluminal coronary angioplasty plus abciximab with or without stenting for acute myocardial infarction complicated by cardiogenic shock.

Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.

Impact of abciximab versus tirofiban on hospital length of stay for PCI patients.

Platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention: the ESPRIT trial: a randomized controlled trial.

Comparison of degree of platelet inhibition by abciximab versus tirofiban in patients with unstable angina pectoris and non-Q-wave myocardial infarction undergoing percutaneous coronary intervention.

P304

1375-1380

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1345/APH.1C363

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9072437

http://www.w3.org/2001/XMLSchema#string

P698

14519056

http://www.w3.org/2001/XMLSchema#string